167 related articles for article (PubMed ID: 31237192)
1. Five-year oncological outcomes after selective neoadjuvant radiotherapy for resectable rectal cancer.
Banwell VC; Phillips HA; Duff MJ; Speake D; McLean C; Williams LJ; He Y; Paterson HM
Acta Oncol; 2019 Sep; 58(9):1267-1272. PubMed ID: 31237192
[No Abstract] [Full Text] [Related]
2. A systematic review and network meta-analysis of randomised controlled trials comparing neoadjuvant treatment strategies for stage II and III rectal cancer.
Simillis C; Khatri A; Dai N; Afxentiou T; Jephcott C; Smith S; Jadon R; Papamichael D; Khan J; Powar MP; Fearnhead NS; Wheeler J; Davies J
Crit Rev Oncol Hematol; 2023 Mar; 183():103927. PubMed ID: 36706968
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of Total Neoadjuvant Therapy With Short-Course Radiotherapy for Resectable Locally Advanced Rectal Cancer.
Chin RI; Otegbeye EE; Kang KH; Chang SH; McHenry S; Roy A; Chapman WC; Henke LE; Badiyan SN; Pedersen K; Tan BR; Glasgow SC; Mutch MG; Samson PP; Kim H
JAMA Netw Open; 2022 Feb; 5(2):e2146312. PubMed ID: 35103791
[TBL] [Abstract][Full Text] [Related]
4. Pathologic Response and Postoperative Complications After Short-course Radiation Therapy and Chemotherapy for Patients With Rectal Adenocarcinoma.
Avila S; Chang GJ; Dasari NA; Smani DA; Das P; Herman JM; Koay E; Koong A; Krishnan S; Minsky BD; Smith GL; Taniguchi C; Taggart MW; Kaur H; Holliday EB
Clin Colorectal Cancer; 2020 Jun; 19(2):116-122. PubMed ID: 32173279
[TBL] [Abstract][Full Text] [Related]
5. Short course radiotherapy and delayed surgery for locally advanced rectal cancer in frail patients: is it a valid option?
Lancellotti F; Solinas L; Sagnotta A; Mancini S; Cosentino LPM; Belardi A; Battaglia B; Mirri MA; Ciabattoni A; Salerno F; Loponte M
Eur J Surg Oncol; 2021 Aug; 47(8):2046-2052. PubMed ID: 33757649
[TBL] [Abstract][Full Text] [Related]
6. Improved Metastasis- and Disease-Free Survival With Preoperative Sequential Short-Course Radiation Therapy and FOLFOX Chemotherapy for Rectal Cancer Compared With Neoadjuvant Long-Course Chemoradiotherapy: Results of a Matched Pair Analysis.
Markovina S; Youssef F; Roy A; Aggarwal S; Khwaja S; DeWees T; Tan B; Hunt S; Myerson RJ; Chang DT; Parikh PJ; Olsen JR
Int J Radiat Oncol Biol Phys; 2017 Oct; 99(2):417-426. PubMed ID: 28871992
[TBL] [Abstract][Full Text] [Related]
7. Short-course preoperative radiotherapy with immediate surgery versus long-course chemoradiation with delayed surgery in the treatment of rectal cancer: a systematic review and meta-analysis.
Zhou ZR; Liu SX; Zhang TS; Chen LX; Xia J; Hu ZD; Li B
Surg Oncol; 2014 Dec; 23(4):211-21. PubMed ID: 25466851
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness analysis of long-course oxaliplatin and bolus of fluorouracil based preoperative chemoradiotherapy vs. 5x5Gy radiation plus FOLFOX4 for locally advanced resectable rectal cancer.
Wang S; Wen F; Zhang P; Wang X; Li Q
Radiat Oncol; 2019 Jun; 14(1):113. PubMed ID: 31234886
[TBL] [Abstract][Full Text] [Related]
9. Neoadjuvant short-course radiotherapy or chemoradiation plus consolidative chemotherapy followed by radical operation for locally advanced rectal cancer.
Lee SF; Yip PL; Wo B; Wong NS; Vellayappan BA; Mamon HJ; Lee FAS
Front Oncol; 2023; 13():1284569. PubMed ID: 38322287
[TBL] [Abstract][Full Text] [Related]
10. Comparison of pathological complete response rates after neoadjuvant short-course radiotherapy or chemoradiation followed by delayed surgery in locally advanced rectal cancer.
Hoendervangers S; Couwenberg AM; Intven MPW; van Grevenstein WMU; Verkooijen HM
Eur J Surg Oncol; 2018 Jul; 44(7):1013-1017. PubMed ID: 29650419
[TBL] [Abstract][Full Text] [Related]
11. Individual participant data pooled-analysis of risk factors for recurrence after neoadjuvant radiotherapy and transanal local excision of rectal cancer: the PARTTLE study.
Arezzo A; Lo Secco G; Passera R; Esposito L; Guerrieri M; Ortenzi M; Bujko K; Perez RO; Habr-Gama A; Stipa F; Picchio M; Restivo A; Zorcolo L; Coco C; Rizzo G; Mistrangelo M; Morino M
Tech Coloproctol; 2019 Sep; 23(9):831-842. PubMed ID: 31388861
[TBL] [Abstract][Full Text] [Related]
12. Fluorouracil-based adjuvant chemotherapy after preoperative chemoradiotherapy in rectal cancer: long-term results of the EORTC 22921 randomised study.
Bosset JF; Calais G; Mineur L; Maingon P; Stojanovic-Rundic S; Bensadoun RJ; Bardet E; Beny A; Ollier JC; Bolla M; Marchal D; Van Laethem JL; Klein V; Giralt J; Clavère P; Glanzmann C; Cellier P; Collette L;
Lancet Oncol; 2014 Feb; 15(2):184-90. PubMed ID: 24440473
[TBL] [Abstract][Full Text] [Related]
13. Korean Society of Coloproctology (KSCP) trial of cONsolidation Chemotherapy for Locally advanced mid or low rectal cancer after neoadjUvant concurrent chemoraDiothErapy: a multicenter, randomized controlled trial (KONCLUDE).
Kim CW; Kang BM; Kim IY; Kim JY; Park SJ; Park WC; Bae KB; Bae BN; Baek SK; Baik SH; Son GM; Lee YS; Lee SH
BMC Cancer; 2018 May; 18(1):538. PubMed ID: 29739356
[TBL] [Abstract][Full Text] [Related]
14. A simplified tumor regression grade correlates with survival in locally advanced rectal carcinoma treated with neoadjuvant chemoradiotherapy.
Beddy D; Hyland JM; Winter DC; Lim C; White A; Moriarty M; Armstrong J; Fennelly D; Gibbons D; Sheahan K
Ann Surg Oncol; 2008 Dec; 15(12):3471-7. PubMed ID: 18846402
[TBL] [Abstract][Full Text] [Related]
15. Metastatic pattern and new primary tumours after neoadjuvant therapy and surgery in rectal cancer.
Frambach P; Pucciarelli S; Perin A; Zuin M; Toppan P; Maretto I; Urso EDL; Spolverato G
Colorectal Dis; 2018 Dec; 20(12):O326-O334. PubMed ID: 30230157
[TBL] [Abstract][Full Text] [Related]
16. Intermediate-fraction neoadjuvant radiotherapy for rectal cancer.
Zhan T; Gu J; Li M; Du C
Dis Colon Rectum; 2013 Apr; 56(4):422-32. PubMed ID: 23478609
[TBL] [Abstract][Full Text] [Related]
17. Changing operative strategy from abdominoperineal resection to sphincter preservation in T3 low rectal cancer after downstaging by neoadjuvant chemoradiation: a preliminary report.
Madbouly KM; Hussein AM
World J Surg; 2015 May; 39(5):1248-56. PubMed ID: 25561197
[TBL] [Abstract][Full Text] [Related]
18. Outcomes of neoadjuvant chemoradiotherapy followed by total mesorectal excision surgery for locally advanced rectal cancer: a single-institution experience.
Tseng MSF; Zheng H; Ng IWS; Leong YH; Leong CN; Yong WP; Cheong WK; Tey JCS
Singapore Med J; 2018 Jun; 59(6):305-310. PubMed ID: 29167909
[TBL] [Abstract][Full Text] [Related]
19. High-dose chemoradiotherapy and watchful waiting for distal rectal cancer: a prospective observational study.
Appelt AL; Pløen J; Harling H; Jensen FS; Jensen LH; Jørgensen JC; Lindebjerg J; Rafaelsen SR; Jakobsen A
Lancet Oncol; 2015 Aug; 16(8):919-27. PubMed ID: 26156652
[TBL] [Abstract][Full Text] [Related]
20. [Evaluation of progression-free survival for locally advanced rectal cancer by MRI after neoadjuvant chemoradiotherapy and total mesorectal excision].
Zhang JX; Yang Z; Fan P; Zhang JJ; Xin L; Hou LN; Du XS; Yang XT
Zhonghua Zhong Liu Za Zhi; 2018 Feb; 40(2):121-126. PubMed ID: 29502372
[No Abstract] [Full Text] [Related]
[Next] [New Search]
